# A Study to Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation Patients

> **NCT01018914** · PHASE4 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 44 (actual)

## Conditions studied

- Liver Transplantation

## Interventions

- **DRUG:** Prograf
- **DRUG:** Advagraf
- **DRUG:** Myfortic

## Key facts

- **NCT ID:** NCT01018914
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2016-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01018914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01018914, "A Study to Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01018914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*